Stay updated on Incyte Press Releases
Sign up to get notified when there's something new on the Incyte Press Releases page.

Latest updates to the Incyte Press Releases page
- CheckyesterdayChange DetectedAdds a new press release announcing the U.S. FDA approval of Atebrioz (zilurgisertib) for adult and pediatric patients with Fibrodysplasia Ossificans Progressiva, dated September 25, 2026. Removes the listing for a press release about a CHMP opinion for Opzelura (ruxolitinib) Cream for adults with moderate atopic dermatitis, dated June 26, 2026.SummaryDifference1%

- Check8 days agoChange DetectedA new press release entry about Incyte's data at the EADV Congress was added (dated September 22, 2026) and an older release about Minjuvi approval in Japan was removed; the total number of displayed releases updated from 37 to 38.SummaryDifference1%

- Check15 days agoNo Change Detected
- Check29 days agoChange DetectedA new press release entry for upcoming investor conferences dated September 1, 2026 was added, and the page now displays 37 total press releases. An older June 14, 2026 release about Mirum Pharmaceuticals and Incyte was removed from the list.SummaryDifference1%

- Check50 days agoChange DetectedA new press release entry for August 7, 2026 titled 'Incyte Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)' was added, increasing the total to 36 releases. The June 13, 2026 EHA data release was removed from the listing, and the page now displays 'Displaying 1 - 10 of 36'.SummaryDifference1%

- Check58 days agoChange DetectedThe press releases list was updated to remove older items and adjust the total count, while the site navigation was refreshed to include Careers-related links and remove a Culture & Careers entry.SummaryDifference6%

- Check72 days agoChange DetectedA new press release item about Incyte's data at the ESMO 2026 congress was added to the list, dated July 17, 2026. A previously listed Zilurgisertib result at ENDO 2026 was removed; the total number of items displayed updated to 33.SummaryDifference1%

Stay in the know with updates to Incyte Press Releases
Enter your email address, and we'll notify you when there's something new on the Incyte Press Releases page.